Urist Marshall

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 72% 68% 82%
Transactions
10 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Urist Marshall's trades of Royalty Pharma PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-02 2026-07-01
PlS Planned sale
33,396 +3.6%
442.54
US$1,898,087 		33,396 +3.6% 442.54 US$1,898,087
2026-07-01 2026-07-01
PrS Proposed sale
99,294
146.73
US$4,096,886 		99,294 146.73 US$4,096,886
2026-06-25 2026-06-24
PlS Planned sale
5,189 +4.6%
255.85
US$3,462,250 		5,189 +4.6% 255.85 US$3,462,250
2026-06-24 2026-06-24
PrS Proposed sale
9,098
55.18
US$502,067 		9,098 55.18 US$502,067
2026-05-21 2026-05-20
PlS Planned sale
13,684 -42.9%
52.75
US$721,838 		13,684 -42.9% 52.75 US$721,838
2026-05-20 2026-05-20
PrS Proposed sale
13,684
52.75
US$721,837 		13,684 52.75 US$721,837
2026-05-15 2026-05-14
PlS Planned sale
13,684 -30.0%
53.06
US$726,137 		13,684 -30.0% 53.06 US$726,137
2026-05-15 2026-05-14
PlS Planned sale
13,684 -30.0%
53.06
US$726,137 		13,684 -30.0% 53.06 US$726,137
2026-05-14 2026-05-14
PrS Proposed sale
13,684
53.06
US$726,138 		13,684 53.06 US$726,138
2026-02-02 2026-01-30
PlS Planned sale
20,000 -100.0%
41.09
US$821,810 		20,000 -100.0% 41.09 US$821,810
2026-01-26 2026-01-23
PlS Planned sale
20,000 -50.0%
40.26
US$805,110 		20,000 -50.0% 40.26 US$805,110
2026-01-20 2026-01-16
PlS Planned sale
20,000 -33.3%
39.52
US$790,346 		20,000 -33.3% 39.52 US$790,346
2026-01-13 2026-01-09
PlS Planned sale
20,000 -25.0%
40.78
US$815,634 		20,000 -25.0% 40.78 US$815,634
2026-01-06 2026-01-02
PlS Planned sale
20,000 -20.0%
38.48
US$769,650 		20,000 -20.0% 38.48 US$769,650
2025-12-29 2025-12-26
PlS Planned sale
20,000 -16.7%
39.32
US$786,380 		20,000 -16.7% 39.32 US$786,380
2025-12-22 2025-12-19
PlS Planned sale
20,000 -14.3%
38.38
US$767,582 		20,000 -14.3% 38.38 US$767,582
2025-12-17 2025-12-16
PlS Planned sale
20,000 -12.5%
38.32
US$766,420 		20,000 -12.5% 38.32 US$766,420
2025-12-09 2025-12-05
PlS Planned sale
18,242 -71.1%
39.15
US$714,224 		18,242 -71.1% 39.15 US$714,224
2025-12-09 2025-12-05
PlS Planned sale
23,334 -12.7%
39.15
US$913,591 		23,334 -12.7% 39.15 US$913,591
2025-12-03 2025-12-01
PlS Planned sale
18,242 -41.6%
39.90
US$727,856 		18,242 -41.6% 39.90 US$727,856
2025-12-03 2025-12-01
PlS Planned sale
23,333 -11.3%
39.93
US$931,633 		23,333 -11.3% 39.93 US$931,633
2025-12-01 2025-12-01
PrS Proposed sale
36,484
39.90
US$1,455,712 		36,484 39.90 US$1,455,712
2023-02-24 2023-02-22
S Sale
23,333 -33.3%
37.30
US$870,239 		23,333 -33.3% 37.30 US$870,239
2022-07-27 2022-07-26
S Sale
19,734 -100.0%
43.20
US$852,461 		19,734 -100.0% 43.20 US$852,461
2022-07-27 2022-07-25
S Sale
3,600 -15.4%
43.05
US$154,985 		3,600 -15.4% 43.05 US$154,985
2022-06-24 2022-06-24
S Sale
23,333 -50.0%
43.19
US$1,007,694 		23,333 -50.0% 43.19 US$1,007,694
2022-05-16 2022-05-16
S Sale
23,333 -33.3%
39.85
US$929,836 		23,333 -33.3% 39.85 US$929,836
2021-06-08 2021-06-07
S Sale
16,568 -100.0%
47.02
US$779,059 		16,568 -100.0% 47.02 US$779,059
2021-06-08 2021-06-04
S Sale
16,566 -50.0%
45.13
US$747,662 		16,566 -50.0% 45.13 US$747,662
2021-06-04 2021-06-02
S Sale
14,566 -30.5%
41.52
US$604,850 		14,566 -30.5% 41.52 US$604,850
2021-05-24 2021-05-21
S Sale
100 -0.2%
41.00
US$4,100 		100 -0.2% 41.00 US$4,100
2021-05-24 2021-05-20
S Sale
1,900 -3.8%
41.08
US$78,059 		1,900 -3.8% 41.08 US$78,059